BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 32588087)

  • 1. Perfluorooctanoic acid (PFOA), perfluorooctane sulfonic acid (PFOS), and perfluorononanoic acid (PFNA) increase triglyceride levels and decrease cholesterogenic gene expression in human HepaRG liver cells.
    Louisse J; Rijkers D; Stoopen G; Janssen A; Staats M; Hoogenboom R; Kersten S; Peijnenburg A
    Arch Toxicol; 2020 Sep; 94(9):3137-3155. PubMed ID: 32588087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impairment of bile acid metabolism by perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid (PFOS) in human HepaRG hepatoma cells.
    Behr AC; Kwiatkowski A; Ståhlman M; Schmidt FF; Luckert C; Braeuning A; Buhrke T
    Arch Toxicol; 2020 May; 94(5):1673-1686. PubMed ID: 32253466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perfluoroalkyl acids-induced liver steatosis: Effects on genes controlling lipid homeostasis.
    Das KP; Wood CR; Lin MT; Starkov AA; Lau C; Wallace KB; Corton JC; Abbott BD
    Toxicology; 2017 Mar; 378():37-52. PubMed ID: 28049043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Per- and polyfluoroalkyl substances impact human spermatogenesis in a stem-cell-derived model.
    Steves AN; Turry A; Gill B; Clarkson-Townsend D; Bradner JM; Bachli I; Caudle WM; Miller GW; Chan AWS; Easley CA
    Syst Biol Reprod Med; 2018 Aug; 64(4):225-239. PubMed ID: 29911897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of polyfluoroalkyl chemical exposure with serum lipids in children.
    Zeng XW; Qian Z; Emo B; Vaughn M; Bao J; Qin XD; Zhu Y; Li J; Lee YL; Dong GH
    Sci Total Environ; 2015 Apr; 512-513():364-370. PubMed ID: 25638651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New approach methodologies: A quantitative in vitro to in vivo extrapolation case study with PFASs.
    Fragki S; Louisse J; Bokkers B; Luijten M; Peijnenburg A; Rijkers D; Piersma AH; Zeilmaker MJ
    Food Chem Toxicol; 2023 Feb; 172():113559. PubMed ID: 36535450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral, morphometric, and gene expression effects in adult zebrafish (Danio rerio) embryonically exposed to PFOA, PFOS, and PFNA.
    Jantzen CE; Annunziato KM; Cooper KR
    Aquat Toxicol; 2016 Nov; 180():123-130. PubMed ID: 27710860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the individual and combined toxicity of perfluoroalkyl substances to human liver cells using biomarkers of oxidative stress.
    Ojo AF; Xia Q; Peng C; Ng JC
    Chemosphere; 2021 Oct; 281():130808. PubMed ID: 34022600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of mouse and human peroxisome proliferator-activated receptors (alpha, beta/delta, gamma) by perfluorooctanoic acid and perfluorooctane sulfonate.
    Takacs ML; Abbott BD
    Toxicol Sci; 2007 Jan; 95(1):108-17. PubMed ID: 17047030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early-life perfluorooctanoic acid (PFOA) and perfluorooctane sulfonic acid (PFOS) exposure cause obesity by disrupting fatty acids metabolism and enhancing triglyceride synthesis in Caenorhabditis elegans.
    Lin TA; Huang CW; Wei CC
    Aquat Toxicol; 2022 Oct; 251():106274. PubMed ID: 36037606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of in vitro hepatotoxic potencies of a series of perfluoroalkyl substances (PFASs) based on gene expression changes in HepaRG liver cells.
    Louisse J; Fragki S; Rijkers D; Janssen A; van Dijk B; Leenders L; Staats M; Bokkers B; Zeilmaker M; Piersma A; Luijten M; Hoogenboom R; Peijnenburg A
    Arch Toxicol; 2023 Apr; 97(4):1113-1131. PubMed ID: 36864359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotoxicity assessment of per- and polyfluoroalkyl substances mixtures in human liver cells (HepG2).
    Ojo AF; Peng C; Ng JC
    Toxicology; 2022 Dec; 482():153359. PubMed ID: 36341878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PPARα/ACOX1 as a novel target for hepatic lipid metabolism disorders induced by per- and polyfluoroalkyl substances: An integrated approach.
    Yang W; Ling X; He S; Cui H; Yang Z; An H; Wang L; Zou P; Chen Q; Liu J; Ao L; Cao J
    Environ Int; 2023 Aug; 178():108138. PubMed ID: 37572494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure to novel and legacy per- and polyfluoroalkyl substances (PFASs) and associations with type 2 diabetes: A case-control study in East China.
    Han X; Meng L; Zhang G; Li Y; Shi Y; Zhang Q; Jiang G
    Environ Int; 2021 Nov; 156():106637. PubMed ID: 33993001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcription of genes involved in fat metabolism in chicken embryos exposed to the peroxisome proliferator-activated receptor alpha (PPARα) agonist GW7647 or to perfluorooctane sulfonate (PFOS) or perfluorooctanoic acid (PFOA).
    Strömqvist M; Olsson JA; Kärrman A; Brunström B
    Comp Biochem Physiol C Toxicol Pharmacol; 2012 Jun; 156(1):29-36. PubMed ID: 22465071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Determination of seven perfluoroalkyl and polyfluoroalkyl substances in serum of pregnant women and evaluation of neonatal neurobehavior based on high performance liquid chromatography-tandem mass spectrometry].
    Wang ZH; Liang FZ; Chen XR; Wu P; Wu W
    Se Pu; 2024 Feb; 42(2):194-202. PubMed ID: 38374600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developmental exposure to perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA) selectively decreases brain dopamine levels in Northern leopard frogs.
    Foguth RM; Flynn RW; de Perre C; Iacchetta M; Lee LS; Sepúlveda MS; Cannon JR
    Toxicol Appl Pharmacol; 2019 Aug; 377():114623. PubMed ID: 31195004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association among serum per- and polyfluoroalkyl substances, lipid profile and metabolic syndrome in Czech adults, HBM-EHES survey 2019.
    Puklová V; Čapková N; Fialová A; Vavrouš A; Žejglicová K; Černá M
    Cent Eur J Public Health; 2023 Dec; 31(4):227-234. PubMed ID: 38309699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiplicity of nuclear receptor activation by PFOA and PFOS in primary human and rodent hepatocytes.
    Bjork JA; Butenhoff JL; Wallace KB
    Toxicology; 2011 Oct; 288(1-3):8-17. PubMed ID: 21723365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeated measurements of per- and polyfluoroalkyl substances (PFASs) from 1979 to 2007 in males from Northern Norway: assessing time trends, compound correlations and relations to age/birth cohort.
    Nøst TH; Vestergren R; Berg V; Nieboer E; Odland JØ; Sandanger TM
    Environ Int; 2014 Jun; 67():43-53. PubMed ID: 24657493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.